Reviewer's report
Title:Serum levels of apoptosis inhibitor of macrophage are associated with
hepatic fibrosis in patients with chronic hepatitis C
Version:1Date:13 January 2014
Reviewer: Emmanuel A Tsochatzis
Reviewer's report:
The authors have addressed most of my queries in a satisfactory way. The issue
remains that AIM does not seem to be a strong predictor of advanced liver
fibrosis - this should be reflected in the abstract. Moreover, the steatosis cut-off
of 5% is NOT clinically significant, given the fact that only 3 patients had a
steatosis of >10%. This should be worded and explained in the discussion.
Level of interest: An article of limited interest
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Nothing to declare
Reviewer's report
Title:Serum levels of apoptosis inhibitor of macrophage are associated with
hepatic fibrosis in patients with chronic hepatitis C
Version:1Date:13 January 2014
Reviewer: Emmanuel A Tsochatzis
Reviewer's report:
The authors have addressed most of my queries in a satisfactory way. The issue
remains that AIM does not seem to be a strong predictor of advanced liver
fibrosis - this should be reflected in the abstract. Moreover, the steatosis cut-off
of 5% is NOT clinically significant, given the fact that only 3 patients had a
steatosis of >10%. This should be worded and explained in the discussion.
Level of interest: An article of limited interest
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Nothing to declare
Please review this paper.
user
Reviewer's report
Title:Serum levels of apoptosis inhibitor of macrophage are associated with
hepatic fibrosis in patients with chronic hepatitis C
Version:1Date:13 January 2014
Reviewer: Emmanuel A Tsochatzis
Reviewer's report:
The authors have addressed most of my queries in a satisfactory way. The issue
remains that AIM does not seem to be a strong predictor of advanced liver
fibrosis - this should be reflected in the abstract. Moreover, the steatosis cut-off
of 5% is NOT clinically significant, given the fact that only 3 patients had a
steatosis of >10%. This should be worded and explained in the discussion.
Level of interest: An article of limited interest
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Nothing to declare
assistant